A dressing that delivers its dose, then disappears.

Keloids don't respond well to what we have.

Excision alone recurs often, and the radiotherapy options that reduce recurrence typically mean multiple clinic visits, room-based equipment, and specialized shielding infrastructure. That treatment burden puts effective options out of reach for a lot of patients who would otherwise benefit from them.

We started IsoVeil to ask a narrower question: what would it take to deliver that dose locally, in a dressing, without the visit burden or the disposal complexity that usually comes with a radioactive source?